国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2014年
3期
345-347
,共3页
霉菌性阴道炎%最小成本分析%药物经济学
黴菌性陰道炎%最小成本分析%藥物經濟學
매균성음도염%최소성본분석%약물경제학
Mycotic vaginitis%Cost-minimum analysis%Pharmacoeconomics
目的 比较治疗外阴阴道霉菌感染的两种不同用药方案的最小成本.方法 运用最小成本分析法(CMA)对氟康唑胶囊+硝酸咪康唑软胶囊+百安洗液(A组)、伊曲康唑胶囊+克霉唑栓+碳酸氢钠溶液(B组)两种给药方案进行药物经济学分析.结果 两组成本分别是215.59元和159.94元,总有效率分别是96.9%和98.4%,总不良反应率分别是14.1%和12.5%,两组总有效率和总不良反应率无统计学差异(P>0.05).结论 在达到相同的治疗效果及总不良反应率无差异的情况下B组的最小成本低于A组,经济学评价效果优于A组.
目的 比較治療外陰陰道黴菌感染的兩種不同用藥方案的最小成本.方法 運用最小成本分析法(CMA)對氟康唑膠囊+硝痠咪康唑軟膠囊+百安洗液(A組)、伊麯康唑膠囊+剋黴唑栓+碳痠氫鈉溶液(B組)兩種給藥方案進行藥物經濟學分析.結果 兩組成本分彆是215.59元和159.94元,總有效率分彆是96.9%和98.4%,總不良反應率分彆是14.1%和12.5%,兩組總有效率和總不良反應率無統計學差異(P>0.05).結論 在達到相同的治療效果及總不良反應率無差異的情況下B組的最小成本低于A組,經濟學評價效果優于A組.
목적 비교치료외음음도매균감염적량충불동용약방안적최소성본.방법 운용최소성본분석법(CMA)대불강서효낭+초산미강서연효낭+백안세액(A조)、이곡강서효낭+극매서전+탄산경납용액(B조)량충급약방안진행약물경제학분석.결과 량조성본분별시215.59원화159.94원,총유효솔분별시96.9%화98.4%,총불량반응솔분별시14.1%화12.5%,량조총유효솔화총불량반응솔무통계학차이(P>0.05).결론 재체도상동적치료효과급총불량반응솔무차이적정황하B조적최소성본저우A조,경제학평개효과우우A조.
Objective To compare the minimum cost of different therapeutic schedules of mycotic vaginitis.Methods The cost analysis method was applied to analyze the pharmacoeconomics of two groups of treatments,which were group A (fluconazole capsule combined with miconazole soft capsule and baian lotion) and group B (itraconazole capsule combined with clotrimazole vaginal suppository and soda solution).Results The costs of two treatments were 215.59 Yuan and 159.94 Yuan with effective rates of 96.9% and 98.4% respectively.Rates of drug adverse reaction were 14.1% and 12.5%.Therefore,therapeutic regimens of two groups had no statistical difference on the respects of the effectiveness and adverse drug reaction (P > 0.05).Conclusion Under the conditions that the therapeutic effect and adverse drug reactions had no statistical significant difference,the minimum cost of group B is lower than that of group A.Consequently the evaluation of pharmacoeconomics of group B is superior to group A.